Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data

Jonette Keri; Leon H. Kircik; Lawrence Green; Glynis Ablon; William Philip Werschler; Emil A. Tanghetti; Zoe D. Draelos; Eric Guenin

doi:10.25251/skin.6.supp.12

Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data

Jonette Keri, Leon H. Kircik, Lawrence Green, Glynis Ablon, William Philip Werschler, Emil A. Tanghetti, Zoe D. Draelos, Eric Guenin

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	s12
Journal	SKIN: Journal of Cutaneous Medicine
Volume	6
Issue number	2
DOIs	https://doi.org/10.25251/skin.6.supp.12
State	Published - 4 Mar 2022

Access to Document

10.25251/skin.6.supp.12

Cite this

@article{91235ba3417b41c7995f54d43f415586,

title = "Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data",

author = "Jonette Keri and Kircik, {Leon H.} and Lawrence Green and Glynis Ablon and Werschler, {William Philip} and Tanghetti, {Emil A.} and Draelos, {Zoe D.} and Eric Guenin",

note = "Funding Information: Jonette Keri has served on speaker{\textquoteright}s bureau for Vyne Therapeutics. Leon Kircik has acted as an investigator, advisor, speaker, and consultant for Ortho Dermatologics. Lawrence Green has served as investigator, consultant, or speaker for Almirall, Cassiopea, Galderma, Ortho Dermatologics, Sol Gel, Sun Pharma, and Vyne. Glynis Ablon has served as a consultant and advisory board member for Galderma, Sinclair, Thermi-Almirall, Erchonia, Sunetics, Nutrafol, and Lifes2Good. William Philip Werschler has served as an investigator for Ortho Dermatologics. Emil Tanghetti has served as speaker for Novartis, Ortho Dermatologics, Sun Pharma, Lilly, Galderma, AbbVie, and Dermira; served as a consultant/clinical studies for Hologic, Ortho Dermatologics, and Galderma; and is a stockholder for Accure. Zoe Draelos received funding from Ortho Dermatologics to conduct the research presented in this poster. Eric Guenin is an employee of Ortho Dermatologics and may hold stock and/or stock options in its parent company.",

year = "2022",

month = mar,

day = "4",

doi = "10.25251/skin.6.supp.12",

language = "English",

volume = "6",

pages = "s12",

journal = "SKIN: Journal of Cutaneous Medicine",

issn = "2574-1624",

publisher = "National Society for Cutaneous Medicine",

number = "2",

}

TY - JOUR

T1 - Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion

T2 - Post Hoc Analysis of Pooled Phase 3 Data

AU - Keri, Jonette

AU - Kircik, Leon H.

AU - Green, Lawrence

AU - Ablon, Glynis

AU - Werschler, William Philip

AU - Tanghetti, Emil A.

AU - Draelos, Zoe D.

AU - Guenin, Eric

N1 - Funding Information: Jonette Keri has served on speaker’s bureau for Vyne Therapeutics. Leon Kircik has acted as an investigator, advisor, speaker, and consultant for Ortho Dermatologics. Lawrence Green has served as investigator, consultant, or speaker for Almirall, Cassiopea, Galderma, Ortho Dermatologics, Sol Gel, Sun Pharma, and Vyne. Glynis Ablon has served as a consultant and advisory board member for Galderma, Sinclair, Thermi-Almirall, Erchonia, Sunetics, Nutrafol, and Lifes2Good. William Philip Werschler has served as an investigator for Ortho Dermatologics. Emil Tanghetti has served as speaker for Novartis, Ortho Dermatologics, Sun Pharma, Lilly, Galderma, AbbVie, and Dermira; served as a consultant/clinical studies for Hologic, Ortho Dermatologics, and Galderma; and is a stockholder for Accure. Zoe Draelos received funding from Ortho Dermatologics to conduct the research presented in this poster. Eric Guenin is an employee of Ortho Dermatologics and may hold stock and/or stock options in its parent company.

PY - 2022/3/4

Y1 - 2022/3/4

UR - http://www.scopus.com/inward/record.url?scp=85136293891&partnerID=8YFLogxK

U2 - 10.25251/skin.6.supp.12

DO - 10.25251/skin.6.supp.12

M3 - Comment/debate

AN - SCOPUS:85136293891

SN - 2574-1624

VL - 6

SP - s12

JO - SKIN: Journal of Cutaneous Medicine

JF - SKIN: Journal of Cutaneous Medicine

IS - 2

ER -